Selective p38 activation in human non-small cell lung cancer.
about
LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1)p38α MAPK is required for arsenic-induced cell transformationAberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersBalance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLCThe rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCCEvaluation of the use of therapeutic peptides for cancer treatmentInterrogating signaling nodes involved in cellular transformations using kinase activity probes.The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingLung carcinoma signaling pathways activated by smoking.Downregulation of P38 phosphorylation correlates with low-grade differentiation and proliferation of lung squamous cell carcinoma.P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancerMicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastomaBCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancerConditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.GADD45α induction by nickel negatively regulates JNKs/p38 activation via promoting PP2Cα expression.Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangementsFunctional genomics in lung cancer and biomarker detection.Imbalanced expression of mitogen-activated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma.Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer.KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases.Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategyAssociation between Carotid Intima-media Thickness and Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism in Chinese Han with Essential HypertensionPhosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer.Mechanisms of Disease: signal transduction in lung carcinogenesis -- a comparison of smokers and never-smokers.p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infectionMagnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer.Role of p38 MAP Kinase Signal Transduction in Solid TumorsThe P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy.p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanismp38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.TES inhibits colorectal cancer progression through activation of p38.
P2860
Q24338854-A2D779D7-0242-4608-AAEF-6B93E6C2BE7FQ28393791-4C11FEBE-2B86-43A8-A5D9-5B49CF1474D1Q28396602-335D766D-80C3-443B-A96E-D6D1CC325E97Q28478252-293053A0-3AF0-467A-9BCF-3CB960BD360BQ28540228-A1DA6EF0-94E5-4CC4-A2CE-4F005304CAE6Q29048586-1DE5BDEB-E130-43E3-B03A-012E2DDE1F98Q30511802-273EAF1B-4EE3-41AF-AAE0-8C6251C55813Q33540291-5D1C40E9-1CF8-46E9-AC7A-50680F0ED3DDQ33579679-7A102278-9115-414F-93C8-101B685D4877Q33623190-26833064-BC3B-44CA-A35D-893395D3FE35Q33778346-FDADB4CB-56F0-4264-A508-776D3882BF88Q33803485-41A37C71-2510-4E4F-AC74-F9F3980409B2Q34257178-913210DA-074C-4E35-A2B2-8A3310103A10Q34313170-388BAB87-078E-42C3-96D7-5D78841DD764Q34356907-5989BCB3-84BA-4377-8E6C-D59F69C022C4Q34432733-2FEF33EB-7227-47B5-82B0-3A3EB96AC3B8Q34516556-6FF976D3-8971-41CB-A9D0-893FAD5323FEQ34638973-1ABB519F-33BF-4A07-9B9D-4DBF5E3DA32DQ35113376-A731480C-FC5E-4310-95C5-A516B445AD32Q35147070-45C6E717-3BD2-41FB-A93C-371FA63BD8BEQ35183995-4F39997F-81F2-45A6-90EE-E71D3A9FDE54Q35301861-1C5170D7-D1B6-4B29-AF1E-2783234CA0BAQ36294822-56B7DAEC-DF62-409C-A472-C7E770D42547Q36511724-D6801424-AB53-4122-A9D9-DAB755678A75Q36657320-B3921BCB-1B68-48DB-AEFE-6BC4D2ADC91DQ36805595-BB352508-8C38-4422-811A-49CC1B110479Q36930676-C90CAD81-531B-4398-A0B1-E1527EABEE15Q36949142-157285FE-E781-4C91-9561-345408CC4B61Q37011327-244544C5-E51B-4C64-9DFE-8DBF26AB3534Q37056598-2D146D57-9EFF-4A36-A5AA-2053A7BF5378Q37217229-1B56427C-DA2F-47DB-AE9A-62B1A886438FQ37224063-E5676871-4930-4C1D-81EF-E195BFD787ECQ37285576-69E002CA-4C31-4793-9A37-C37BAB256FDBQ37301756-F22807EA-2A4F-4142-A12F-6F5583C6FE2EQ37375221-9B384069-71A8-405A-A9ED-DAC3C276D308Q37392558-37B7D069-D191-4C73-82F8-221694B7441DQ37414070-30B756C6-651D-4CEE-B57B-44E0DB03FF3AQ37448644-70713574-B823-4BF5-8B75-9CDE1CABF1DBQ37548547-A922665E-EE9D-4F0C-9C7C-261B1A63A887Q37564565-2144D6D6-5016-46B6-AF2C-1886130AF364
P2860
Selective p38 activation in human non-small cell lung cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Selective p38 activation in human non-small cell lung cancer.
@en
type
label
Selective p38 activation in human non-small cell lung cancer.
@en
prefLabel
Selective p38 activation in human non-small cell lung cancer.
@en
P2093
P356
P1476
Selective p38 activation in human non-small cell lung cancer.
@en
P2093
Alissa K Greenberg
Kam Meng Tchou-Wong
Sharmila Basu
Theodore C Lee
Ting-an Yie
William N Rom
P304
P356
10.1165/AJRCMB.26.5.4689
P577
2002-05-01T00:00:00Z